Here are 51 books that Bad Pharma fans have personally recommended if you like
Bad Pharma.
Shepherd is a community of 12,000+ authors and super readers sharing their favorite books with the world.
I am a former Shakespeare scholar who became increasingly concerned about the climate crisis after I had a son and started worrying about the world he would inherit after I died. I began to do research into climate communication, and I realized I could use my linguistic expertise to help craft messages for campaigners, policymakers, and enlightened corporations who want to drive climate action. As I learned more about the history of climate change communication, however, I realized that we couldn’t talk about the crisis effectively without knowing how to parry climate denial and fossil-fuel propaganda. So now I also research and write about climate disinformation, too.
This book is the classic study that you must read if you’re going to understand how fossil fuel interests set out to create climate denial. Taking their playbook from the tobacco lobby, these interests hired unscrupulous researchers to do work that inspired doubt about climate science.
This book documents a core truth: climate change isn’t a tragedy; it’s a crime. This book will introduce you to the criminals and show you their MO.
The U.S. scientific community has long led the world in research on such areas as public health, environmental science, and issues affecting quality of life. Our scientists have produced landmark studies on the dangers of DDT, tobacco smoke, acid rain, and global warming. But at the same time, a small yet potent subset of this community leads the world in vehement denial of these dangers.
Merchants of Doubt tells the story of how a loose-knit group of high-level scientists and scientific advisers, with deep connections in politics and industry, ran effective campaigns to mislead the public and deny well-established scientific…
I am an economist who came to realize that the marketplace of ideas was a political doctrine, and not an empirical description of how we came to know what we think we know. Science has never functioned in the same manner across centuries; it was only during my lifetime that it became recast as a subset of market reality. I have spent a fair amount of effort exploring how economics sought to attain the status of a science; but now the tables have turned. It is now scientists who are trained to become first and foremost market actors, finally elevating the political dominance of the economists.
If Oreskes & Conway documented the historical trend, Michaels shows what the daily battle over the implications of science for governance is like from within. As former Assistant Secretary for Labor for OSHA, he recounts the never-ending combat over how science is generated and interpreted when it comes to the safety and comprehension of the American public. From dark money to hired guns to compromised scientists, he puts names and faces to the war on science, with truth as the first casualty.
America is a country of everyday crises - big, long-spanning problems that persist, mostly unregulated, despite their toll on the country's health and vitality. And for every case of government inaction on one of these issues, there is a set of familiar, doubtful refrains: The science is unclear. The data is inconclusive. Regulation is unjustified. It's a slippery slope.
Is it?
The Triumph of Doubt traces the ascendance of science-for-hire in American life and government, from its origins in the tobacco industry in the 1950s to its current manifestations across government, public policy, and even…
I am an economist who came to realize that the marketplace of ideas was a political doctrine, and not an empirical description of how we came to know what we think we know. Science has never functioned in the same manner across centuries; it was only during my lifetime that it became recast as a subset of market reality. I have spent a fair amount of effort exploring how economics sought to attain the status of a science; but now the tables have turned. It is now scientists who are trained to become first and foremost market actors, finally elevating the political dominance of the economists.
I don’t often praise edited collections, but this book is the most clear-eyed discussion of our current predicament in the face of worsening global warming I have ever encountered. The authors argue that the political deployment of geoengineering to ‘save’ us has become essentially a foregone conclusion—forget all that wishful Green New Deal happy talk. They then proceed to argue out the various potential political scenarios concerning what this means for future politics. Read this and weep.
Geoengineering is the deliberate and large-scale intervention in the Earth's climate system in an attempt to mitigate the adverse effects of global warming. Now that climate emergency is upon us, claims that geoengineering is inevitable are rapidly proliferating. How did we get into this situation where the most extreme path now seems a plausible development? Is it an accurate representation of where we are at? Who is this “we” who is talking? What options make it onto the table? Which are left out? Whom does geoengineering serve? Why is the ensemble of projects that goes by that name so salient,…
I am an economist who came to realize that the marketplace of ideas was a political doctrine, and not an empirical description of how we came to know what we think we know. Science has never functioned in the same manner across centuries; it was only during my lifetime that it became recast as a subset of market reality. I have spent a fair amount of effort exploring how economics sought to attain the status of a science; but now the tables have turned. It is now scientists who are trained to become first and foremost market actors, finally elevating the political dominance of the economists.
Edwards revealed how the very architecture of early computers owed a debt to the political structures of the Cold War. The innovation of a command/control/information infrastructure set the template for military regimentation, and subsequently for the surveillance society we currently inhabit. The story of how cybernetics—a field that never quite made the grade as pure science—nevertheless conquered the culture, is fascinating.
The Closed World offers a radically new alternative to the canonical histories of computers and cognitive science. Arguing that we can make sense of computers as tools only when we simultaneously grasp their roles as metaphors and political icons, Paul Edwards shows how Cold War social and cultural contexts shaped emerging computer technology―and were transformed, in turn, by information machines.
The Closed World explores three apparently disparate histories―the history of American global power, the history of computing machines, and the history of subjectivity in science and culture―through the lens of the American political imagination. In the process, it reveals intimate…
I’ve always been in love with the idea of love. I didn’t know what that feeling was like for a long time–not being in love myself–so I grew attached to fictionalised worlds that brought those ideas to life. I’ve always been the person who smiles at a meet-cute or feels that warm, fuzzy feeling inside when the couple you’ve been rooting for the last two hundred pages finally kisses. I want them to know how exciting it can be to feel loved and experience that through the creation of stories. This is why romance is, and likely always will be, a huge thematic influence on all forms of my work.
A gut-wrenching but provokingly beautiful story that highlights an illness that isn’t spoken much about in fiction.
The relationship between Stella and Will is such a heartbreakingly warming story that gives the reader a new-found understanding of how cystic fibrosis can impact an individual's life. I enjoy reading stories involving new, important conversations that need to be had, especially on topics we don’t often see in novels.
I think it’s important for writing to help spread awareness. It’s something that I myself want to do more in my own work.
Also a major motion picture starring Cole Sprouse and Haley Lu Richardson! Goodreads Choice Winner, Best Young Adult Fiction of 2019
In this #1 New York Times bestselling novel that’s perfect for fans of John Green’s The Fault in Our Stars, two teens fall in love with just one minor complication—they can’t get within a few feet of each other without risking their lives.
Can you love someone you can never touch?
Stella Grant likes to be in control—even though her totally out of control lungs have sent her in and out of the hospital most of her life. At…
Frank S. David, MD, PhD leads the biopharma consulting firm Pharmagellan, where he advises drug companies and investors on R&D and business strategy. He is also an academic researcher on strategy, regulation, and policy in the drug industry; a member of the Harvard-MIT Center for Regulatory Science; and a former blogger at Forbes.com.
This account of the early years of Vertex Pharmaceuticals, from its inception as a scrappy start-up to its early work in HIV, is a must-read classic for anyone interested in how science turns into new drugs. Barry Werth’s journalistic play-by-play is a cinematic, true-to-life picture of the strategic decisions, real-world challenges, and larger-than-life personalities that underlie modern drug development. His riveting follow-up, The Antidote, continues the saga by taking readers through Vertex’s pathbreaking work to transform the care of patients with hepatitis C and cystic fibrosis.
In my younger days, as the son of a medical professor and a public health nurse, I was more interested in healing society than patients. But my political interests and research agenda as a professor of political science ultimately led back to medicine. I found that profit-maximizing market competition in health care failed miserably to promote value in therapeutics and economize on society’s scarce resources. I became aware of the neglect of public health to prevent disease for vulnerable groups in society and save money as well as lives. Pervasive and enduring economic conflicts of interest in the medical-industrial complex bear primary responsibility for severe deficits in quality, equality, and economy in American health care.
I found, as a history buff, The Struggle for Drug Reform to be an eye-opener about how America’s exceptionally high drug prices among other deficits in health care quality and coverage resulted from the past exercise of power by the pharmaceutical industry, the lynchpin of America’s “medico-industrial complex.”
I was impressed by historian Tobbell’s meticulously researched account of the industry’s strategic alliances with self-interested medical scientists, not just conservative political forces, and its use of anti-communist propaganda to fight off the threat of drug pricing regulations.
I personally found important her discussions of how the industry allied with the American Medical Association against universal health care, against FDA demands for evidence about drug efficacy and safety before allowing drugs on the market, and against the threat to its profits from generic drugs.
Since the 1950s, the American pharmaceutical industry has been heavily criticized for its profit levels, the high cost of prescription drugs, drug safety problems, and more, yet it has, together with the medical profession, staunchly and successfully opposed regulation. "Pills, Power, and Policy" offers a lucid history of how the American drug industry and key sectors of the medical profession came to be allies against pharmaceutical reform. It details the political strategies they have used to influence public opinion, shape legislative reform, and define the regulatory environment of prescription drugs. Untangling the complex relationships between drug companies, physicians, and academic…
In my younger days, as the son of a medical professor and a public health nurse, I was more interested in healing society than patients. But my political interests and research agenda as a professor of political science ultimately led back to medicine. I found that profit-maximizing market competition in health care failed miserably to promote value in therapeutics and economize on society’s scarce resources. I became aware of the neglect of public health to prevent disease for vulnerable groups in society and save money as well as lives. Pervasive and enduring economic conflicts of interest in the medical-industrial complex bear primary responsibility for severe deficits in quality, equality, and economy in American health care.
I find Angell’sThe Truth About the Drug Companies extremely valuable for teaching students about how the pharmaceutical industry translates high profits into power resources to protect and increase those profits over time.
The former New England Journal of Medicine editor exposed how drug companies enlist politicians, the FDA, and medical academia for their cause. And armies of lawyers to extend monopoly marketing rights for years.
It was my first introduction to how they spend more on marketing than research, much of that on “copy-cat” drugs of dubious superiority to ones with expired patents.
As a tax (and high drug price) payer, I was disturbed to learn how they use government funds for basic research and then rig and spin their reporting of clinical studies to inflate their products’ therapeutic value and underplay their risks.
During her two decades at The New England Journal of Medicine, Dr. Marcia Angell had a front-row seat on the appalling spectacle of the pharmaceutical industry. She watched drug companies stray from their original mission of discovering and manufacturing useful drugs and instead become vast marketing machines with unprecedented control over their own fortunes. She saw them gain nearly limitless influence over medical research, education, and how doctors do their jobs. She sympathized as the American public, particularly the elderly, struggled and increasingly failed to meet spiraling prescription drug prices. Now, in this bold, hard-hitting new book, Dr. Angell exposes…
I am peculiar. Really. I’m an autistic, non-binary, PhD historian who writes weird non-fiction books—and I read them, too. Among my friends are folks like Mary Roach (Fuzz, Stiff, Bonk, Gulp), Deborah Blum (Poisoner’s Handbook), and Ed Yong (I contain Multitudes, An Immense World). Yet, despite there being so many amazing books about strange facts, it's still hard to find them in one place. Your average bookstore doesn’t have a “peculiar” section, for some reason. That’s why I started myPeculiar Book ClubYouTube show: I wanted there to be a home for authors and readers of the quirky, quizzical, curious, and bizarre. And then I thought, hey, why not make a book list, too.
Two pharmacists sit in a Boston courtroom accused of murder. The weapon: a fungus. The death count: 100 and rising. These facts set the stage for a true-crime thriller by investigative journalist Jason Dearen, and it has the makings of a horror movie. There’s scientific hubris, sketchy ethics, a cover-up, and a monster, too: a slimy, sticky, fungal mold that infected patients and began eating their brains alive. It’s riveting, packed with information about how fungal spores managed to contaminate a medical supply chain, and frankly hard to put down. I have done my share of forensic research, and never have I encountered killer fungus before; I consider this an unmissable book.
An award-winning investigative journalist's horrifying true crime story of America's deadliest drug contamination outbreak and the greed and deception that fueled it.
Two pharmacists sit in a Boston courtroom accused of murder. The weapon: the fungus Exserohilum rostratum. The death count: 100 and rising. Kill Shot is the story of their hubris and fraud, discovered by a team of medical detectives who raced against the clock to hunt the killers and the fungal meningitis they'd unleashed.
"Bloodthirsty" is how doctors described the fungal microbe that contaminated thousands of drug vials produced by the New England Compounding Center (NECC). Though NECC…
In my younger days, as the son of a medical professor and a public health nurse, I was more interested in healing society than patients. But my political interests and research agenda as a professor of political science ultimately led back to medicine. I found that profit-maximizing market competition in health care failed miserably to promote value in therapeutics and economize on society’s scarce resources. I became aware of the neglect of public health to prevent disease for vulnerable groups in society and save money as well as lives. Pervasive and enduring economic conflicts of interest in the medical-industrial complex bear primary responsibility for severe deficits in quality, equality, and economy in American health care.
If you think that medical journals published by respected medical societies are full of good science, think again.
For me, Abramson’s Sickeningnailed the case for a conclusion that the net effect of the many hundreds of medical journals published here and around the world is to subtract from the sum of human medical knowledge.
Abramson, as an expert witness in criminal and civil cases against drug companies, draws in part on subpoenaed documents to expose how medical science, as part of the entire medical-industrial complex, is corrupted from start to finish by the drug industry’s funding of most clinical trials, their control over the data analysis, and even their ghost-writing of articles submitted to journals.
New and disturbing was the withholding of clinical trials’ raw data from journals’ peer reviewers. Instead, they get biased summaries bearing drug manufacturers’ fingerprints.
The inside story of how Big Pharma’s relentless pursuit of ever-higher profits corrupts medical knowledge—misleading doctors, misdirecting American health care, and harming our health.
The United States spends an excess $1.5 trillion annually on health care compared to other wealthy countries—yet the amount of time that Americans live in good health ranks a lowly 68th in the world. At the heart of the problem is Big Pharma, which funds most clinical trials and therefore controls the research agenda, withholds the real data from those trials as corporate secrets, and shapes most of the information relied upon by health care professionals.…
